Release Date: 26/10/12 13:42 Summary: Appendix 3Y - Killinger Price Sensitive: No Download Document 73.24KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%